← All indications
Depression
Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
Drugs by status
Approved for this indication (43)
- citalopram
- nortriptyline
- venlaxafine
- citicoline
- butylparaben sodium
- xiaoyao
- imipramine
- escitalopram
- methylfolate
- tranylcypromine
- tryptophan
- mianserin
- shuganjieyu
- naloxone
- escalitopram
- dehydroepiandrosterone
- nomifensine
- doxepin
- protriptyline
- reboxetine
- amitriptylinoxide
- esketamine
- flurothyl
- benactyzine
- phenelzine
- tybatran
- trimipramine
- liothyronine
- s-adenosyl methionine
- zimeldine
- +13 more
Phase 4 trials (127)
- tibolone
- hypericum perforatum
- xiwujia
- emtricitabine
- ibuprofen
- succinylcholine
- vilazodone
- aripiprazole
- acetaminophen
- melatonin
- sertraline
- lorazepam
- conjugated equine estrogens
- amisulpride
- brexanolone
- fentanyl
- b multivitamins
- mirtazapine
- amitriptyline
- omeprazole
- fluoxetine
- memantine
- nicotine
- amphetamine
- shu gan yi yang
- bazedoxifene
- alendronic acid
- eszopiclone
- vitamin d3
- methylphenidate
- +97 more
Phase 3 trials (107)
- human fecal microbiota
- samidorphan
- leucovorin
- bromazepam
- clozapine
- milnacipran
- flibanserin
- amibegron
- cyb003
- glucose monohydrate
- ansofaxine
- phospholipids
- nicotergoline
- clobazam
- psilocybin
- alprazolam
- chlorprothixene
- maca root
- fish oil
- paliperidone
- lisdexamfetamine
- minocycline
- diazepam
- oxcarbazepine
- soybean oil
- tiaprizal
- armodafinil
- olive
- bromperidol
- fluspirilene
- +77 more
Phase 2 trials (121)
- leuprolide
- bifidobacteria
- chen pi
- cyclophosphamide
- disodium adenosine triphosphate
- ethanol
- lysine
- clemastine
- lu aa34893
- (2r,6r)-hydroxynorketamine hydrochloride
- curcumae radix
- sarcosine
- vitamin c
- simvastatin
- bezafibrate
- filorexant
- decoglurant
- ubiquinone
- l-4-cl-kyn
- org-34517
- ayahuasca
- guanfacine
- ketanserin
- trastuzumab
- Methoxypregnenolone
- jnj-39393406
- yuxintine
- du125530
- org-26576
- hepatitis-a virus (inactivated) / hepatitis-b surface antigen
- +91 more
Phase 1 trials (49)
- digoxin
- ps13
- alpha-lipoic acid
- sp-624
- abbv-cls-7262
- nop-1a
- fludrocortisone
- gsk163090
- ipratropium
- jiedu tongluo
- azd-7325
- onabotulinumtoxinA
- raltegravir
- amivantamab-vmjw
- bpn14770
- d-serine
- ly2940094
- kava
- piperine
- pf4455242
- pyridoxamine
- nicotinamide
- perampanel
- lipopolysaccharide
- yinhsing
- glycopyrronium
- urea
- visibiome
- sodium phytate
- bms-866949
- +19 more
Other trials (96)
- dydrogesterone
- lactobacillus reuteri
- almond
- sulfadoxine
- rabeprazole
- glutathione
- wuling
- cobalamin
- tamoxifen
- blueberry
- dental pulp mesenchymal stem cells
- biotin
- Hydroxytryptophan
- egg
- divalproate
- schisandra chinensis
- eschscholtzia
- magnesium sulfate
- eicosapentanoic acid
- deanxit
- thiopental
- lactococcus lactis
- corn
- ghrelin
- prazosin
- seaweed
- mosapride
- glucose
- zinc dichloride
- omega-3 fatty acids
- +66 more
Organizations
Organization Involved with Phase 4 Indications (315)
- Wuhan University
- Marriott Family and Foundation
- Government of Taiwan
- University of Erlangen-Nuremberg
- Tufts University
- University of Wisconsin
- Hangzhou Seventh People's Hospital
- University of Ottawa
- Capital Clinical Research Associates, LLC
- National Institute on Aging (NIA)
- Providence Health & Services
- Leiden University
- Johns Hopkins University
- National University of Ireland
- Government of Finland
- Medtronic
- German Federal Ministry of Education and Research
- Peking University
- Jefferson Clinic, P.C.
- HolsboerMaschmeyer NeuroChemie GmbH
- Maastricht University
- Kai-Suan Psychiatric Hospital
- Krankenhaus Bethanien gGmbH
- Emory University
- New York University
- Hoosier Cancer Research Network
- University of Washington
- Finnish Foundation for Alcohol Studies
- Boehringer Ingelheim
- University of Texas, San Antonio
- +285 more
Organization Involved with Phase 3 Indications (139)
- Zentrum für Integrative Psychiatrie
- Simon Fraser University
- Stats Collaborative
- Mochida Pharmaceutical Company, Ltd.
- University of Connecticut
- Catalysis SL
- The S. Daniel Abraham International Center for Health and Nutrition
- Ontario HIV Treatment Network
- University of Grenoble
- Ruhr University Bochum
- University of Bonn
- Lee's Pharmaceutical
- University of Oklahoma
- Target Health Inc.
- Austin Health
- University of Freiburg
- University of Lausanne
- Technical University of Munich
- Cassella AG
- Shijiazhuang Pharma Group (CSPC)
- University Hospital Plymouth NHS Trust
- The Royal's Institute of Mental Health Research
- Beijing First Hospital of integrated Chinese and Western Medicine
- Midwest Clinical Research Center, Ohio
- University of Toyama
- University of Heidelberg
- Chinese University of Hong Kong
- University Hospitals Cleveland Medical Center
- Axsome Therapeutics, Inc.
- University of Vermont
- +109 more
Organization Involved with Phase 2 Indications (164)
- Sadat City University
- Government of Belgium
- Department of Defense
- Concordia University
- ADIR Association
- FGK Clinical Research GmbH
- Leningrad Addiction Treatment & Research Center
- FutureSearch Trials
- COMPASS Pathways
- NorthCoast Clinical Trials
- Melbourne Health
- University of Cambridge
- University of New South Wales
- Oregon Center for Clinical Investigations, Inc
- Rijnstate Hospital
- American Cancer Society, Inc.
- Sirtsei Pharmaceuticals, Inc.
- Chase Therapeutics
- Northbrooke Research Center
- AlzChem AG
- Kun Ming KingBio Biotechnology Co. LTD
- M's Science Corporation
- University of Sydney
- Badalona Hospital Germans Trias i Pujol
- Seton Healthcare Family
- The Mediterranean Institute for the Advance of Biotechnology and Health Research
- Hanyang University
- University of Basel
- Gulfcoast Clinical Research Center
- University of Malaga
- +134 more
Organization Involved with Phase 1 Indications (37)
- California Clinical Trials
- Retina Associates of Cleveland
- Trinity College
- Navitor Pharmaceuticals, Inc.
- Novum Pharmaceutical Research Services
- Central Visitation, Region Hovedstaden
- Sichuan Huaxi Hopsital
- NuBiyota
- Kufa University
- Shenox Pharmaceuticals, LLC
- Taipei Veteran General hospital
- American Psychiatric Association
- Chonbuk National University
- St. Louis Clinical Trials, LC
- The Pittsburgh Foundation
- Heffter Research Institute
- PPD
- University of Houston
- National Network of Depression Centers
- Sandoz
- Phoenix International Life Science Inc.
- Retina Associates of Cleveland, Inc
- St Patrick's Hospital
- Xiyuan Hospital
- DongWha Pharmaceutical Company
- Genentech
- Radboud University
- Biodecision, Inc.
- Chicago Research Center, Inc.
- Hengrui Therapeutics, Inc.
- +7 more
Organization Involved with Other Experimental Indications (104)
- François Rabelais University
- Federal University of Minas Gerais
- Fourth Hospital of Shijiazhuang City
- West China Hospital
- Kenya Medical Research Institute
- Fudan University
- King Edward Medical University
- Asthma UK
- Technical University of Dresden
- Rowan University
- Lawley Pharmaceuticals
- University of Turku
- Ospedale Regionale di Lugano
- Haidian Maternal and Child Health Hospital
- China Health Promotion Foundation
- Aalborg University
- National Research Foundation of Korea
- Health and Family Welfare Department, Government of Gujarat, India
- The Nazareth Hospital, Israel
- Yeshiva University
- Florida Atlantic University
- Maternal and Child Health Hospital, Jiading District
- Tongzhou Maternal and Child Healthcare Hospital of Beijing
- Nicolaus Copernicus University
- Advanced Biomedical Research
- Taichung Veterans General Hospital
- Tanta University
- The Korean Society of Ginseng
- Premier Research Group
- Beijing Chaoyang District Maternal and Child Health Care Hospital
- +74 more